logo

HQY

Healthequity·NASDAQ
--
--(--)
--
--(--)
8.21 / 10
Outperform

Fundamental analysis reveals a robust profile: key metrics such as Net Cash Flow from Operating Activities per Share (YoY growth 39.3%), Basic Earnings Per Share (YoY growth 70.8%), and Diluted Earnings Per Share (YoY growth 70.3%) all rank in the top quartile, contributing to an 8.2/10 score. However, Net income-Revenue (0.343) and Revenue-MV (0.157) show relative weaknesses, tempering the overall outlook. The Asset-MV factor (-0.503) places HQY in group 2, while Cash-MV (0.599) is in group 4, indicating mixed asset and cash positions. These factors collectively suggest a fundamentally sound company with room for operational optimization.

Fundamental(8.21)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value0.16
Score0/3
Weight-5.41%
1M Return-2.93%
Net cash flow from operating activities per share (YoY growth rate %)
Value39.30
Score3/3
Weight12.50%
1M Return5.16%
Net income-Revenue
Value0.34
Score1/3
Weight5.11%
1M Return2.53%
Basic earnings per share (YoY growth rate %)
Value70.77
Score3/3
Weight11.07%
1M Return4.75%
Total profit (YoY growth rate %)
Value54.63
Score3/3
Weight14.40%
1M Return6.14%
Net cash flow from operating activities (YoY growth rate %)
Value39.96
Score3/3
Weight12.79%
1M Return5.21%
Diluted earnings per share (YoY growth rate %)
Value70.31
Score3/3
Weight11.97%
1M Return5.10%
Asset-MV
Value-0.50
Score3/3
Weight9.98%
1M Return4.29%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value73.58
Score3/3
Weight9.49%
1M Return4.09%
Cash-MV
Value0.60
Score3/3
Weight18.10%
1M Return7.22%
Is HQY fundamentally strong?
  • HQY scores 8.21/10 on fundamentals and holds a Discounted valuation at present. Backed by its 7.79% ROE, 14.86% net margin, 46.54 P/E ratio, 3.18 P/B ratio, and 98.21% earnings growth, these metrics solidify its Outperform investment rating.